Notch1 loss of heterozygosity causes vascular tumors and lethal hemorrhage in mice.
The role of the Notch signaling pathway in tumor development is complex, with Notch1 functioning either as an oncogene or as a tumor suppressor in a context-dependent manner. To further define the role of Notch1 in tumor development, we systematically surveyed for tumor suppressor activity of Notch1 in vivo. We combined the previously described Notch1 intramembrane proteolysis-Cre (Nip1::Cre) allele with a floxed Notch1 allele to create a mouse model for sporadic, low-frequency loss of Notch1 heterozygosity. Through this approach, we determined the cell types most affected by Notch1 loss. We report that the loss of Notch1 caused widespread vascular tumors and organism lethality secondary to massive hemorrhage. These findings reflected a cell-autonomous role for Notch1 in suppressing neoplasia in the vascular system and provide a model by which to explore the mechanism of neoplastic transformation of endothelial cells. Importantly, these results raise concerns regarding the safety of chronic application of drugs targeting the Notch pathway, specifically those targeting Notch1, because of mechanism-based toxicity in the endothelium. Our strategy also can be broadly applied to induce sporadic in vivo loss of heterozygosity of any conditional alleles in progenitors that experience Notch1 activation.
Department of Developmental Biology, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Zhenyi
Z
Liu
Ahu
A
Turkoz
Erin N
EN
Jackson
Joseph C
JC
Corbo
John A
JA
Engelbach
Joel R
JR
Garbow
David R
DR
Piwnica-Worms
Raphael
R
Kopan
D000818:Animals; D018450:Disease Progression; D006470:Hemorrhage / Q000473:pathology*; D006801:Humans; D019656:Loss of Heterozygosity; D008279:Magnetic Resonance Imaging; D051379:Mice; D051881:Receptor, Notch1 / Q000235:genetics* / Q000378:metabolism*; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology; D015996:Survival Rate; D019043:Vascular Neoplasms / Q000473:pathology* / Q000503:physiopathology*
D051881:Receptor, Notch1; D011993:Recombinant Fusion Proteins
Dev Neurosci. 2006;28(1-2):81-91
16508306
Cancer Res. 2009 Apr 15;69(8):3657-64
19351831
FASEB J. 2005 Jun;19(8):1027-9
15774577
Circ Res. 2002 Nov 29;91(11):999-1006
12456485
Mol Cell Biol. 2004 Oct;24(20):8813-22
15456857
Cell Stem Cell. 2008 Oct 9;3(4):429-41
18940734
Genome Res. 2009 Nov;19(11):2081-9
19797679
Nature. 2006 Dec 21;444(7122):1083-7
17183323
Nature. 2006 Dec 21;444(7122):1032-7
17183313
Methods Mol Med. 1998;9:319-28
21374472
J Cell Sci. 2010 Jan 15;123(Pt 2):213-24
20048339
Dev Dyn. 2008 Apr;237(4):1144-52
18330927
Cancer Res. 2005 Sep 1;65(17):7530-2
16140913
Nat Rev Cancer. 2007 May;7(5):327-31
17457300
Nature. 2010 Feb 11;463(7282):E6-7
20147986
Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9209-14
11481484
Science. 2004 Oct 8;306(5694):269-71
15472075
Cell Stem Cell. 2009 Aug 7;5(2):168-77
19664991
Nature. 2009 Nov 12;462(7270):182-8
19907488
Blood. 2010 Dec 16;116(25):5443-54
20829372
Genes Dev. 1994 Mar 15;8(6):707-19
7926761
FASEB J. 2008 May;22(5):1606-17
18096813
Curr Biol. 2003 Aug 5;13(15):1348-54
12906797
Cell Mol Life Sci. 2007 Nov;64(21):2746-62
17687513
Nat Genet. 2003 Mar;33(3):416-21
12590261
Development. 2007 Feb;134(3):535-44
17215306
Development. 1995 May;121(5):1533-45
7789282
Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10623-8
12963823
Cell. 2009 Apr 17;137(2):216-33
19379690
Dev Neurosci. 2006;28(1-2):102-17
16508308
Nat Genet. 1999 Jan;21(1):70-1
9916792
Cancer Cell. 2009 Jul 7;16(1):55-66
19573812
Nat Protoc. 2008;3(6):1085-91
18546599
BMC Dev Biol. 2001;1:4
11299042
Genes Dev. 2000 Jun 1;14(11):1343-52
10837027
Nature. 2010 Apr 15;464(7291):1052-7
20393564
PLoS Biol. 2008 May 27;6(5):e123
18507503
Genes Dev. 2004 Nov 15;18(22):2730-5
15545631
Nat Methods. 2005 Aug;2(8):607-14
16094386
PLoS One. 2010 Feb 08;5(2):e9094
20161710
Nature. 2005 Jun 16;435(7044):959-63
15959515
EMBO Rep. 2008 Apr;9(4):377-83
18274550
Dev Cell. 2007 Aug;13(2):242-53
17681135